Brief: Corcept Therapeutics Q3 EPS USD 0.16
04/11/2025 21:05
Nov 04 (Reuters) - Corcept Therapeutics Q3 revenue USD 207.638 million vs. IBES estimate USD 223.8 million. Q3 net income USD 19.668 million outlook FY revenue USD 800-850 million
Recent news on Corcept Therapeutics Incorporated
See all newsDrugmaker Corcept seeks to bar ex-judge's views in Teva antitrust case
Live Markets: US earnings forecast jumps further after key reports this week
Live Markets: Who's next for the S&P 500? The clock is ticking
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Corcept Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary